Gastric cancer, the fifth most frequent cancer worldwide and the fifth major cause of cancer-related fatalities has minimal study on IL-17A, and its function in gastric cancer development and therapy remains contentious (7–10). This evidence concerns the gene IL17A and gastric cancer.